Happy New Year! We are looking forward to 2014 and all that it will bring. We finished off 2013 on a high note: receiving our No Objection Letter (NOL) from Health Canada! This of course, means we have regulatory approval … Continue reading →
Posted inNews|Comments Off on Trial Approved by Health Canada
This site is regularly updated with news about our research on inherited retinal conditions and their potential therapies. For general information about our choroideremia gene therapy clinical trial, click FAQs About Our Clinical Trial. For the progress and results of our trial, click here.